Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	99612
Country	China

Received	2024-07-26 01:26
Peer-Review Started	2024-07-26 01:26
To Make the First Decision
Return for Revision	2024-10-20 10:55
Revised	2024-10-31 13:16
Second Decision	2024-11-25 02:34
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-11-25 09:15
Articles in Press	2024-11-25 09:15
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-11-26 10:28
Typeset the Manuscript	2024-11-29 13:55
Publish the Manuscript Online	2025-01-18 08:12

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Surgery
Manuscript Type	Letter to the Editor
Article Title	Hepatic artery infusion chemotherapy: A resurgence
Manuscript Source	Invited Manuscript
All Author List	Andrew Kai-Yip Fung and Kenneth Siu Ho Chok
ORCID	Author(s) ORCID Number Andrew Kai-Yip Fung http://orcid.org/0000-0002-7731-1638 Kenneth Siu Ho Chok http://orcid.org/0000-0001-7921-3807
Funding Agency and Grant Number
Corresponding Author	Kenneth Siu Ho Chok, MD, Professor, Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong 999077, China. kennethchok@gmail.com
Key Words	Hepatocellular carcinoma; Hepatic artery infusion chemotherapy; Immunotherapy; Target therapy; Transarterial chemoembolisation
Core Tip	In the current landscape of accumulating knowledge of hepatocellular carcinoma (HCC) tumour biology and developments in systemic therapies, the management of advanced HCC has become increasingly complicated. For hepatic arterial infusion chemotherapy (HAIC) to be first line treatment for advanced HCC, the morbidity of hepatic artery port insertion must be at a low level, the HAIC regimens must be standardised, the optimal combination treatment strategy with HAIC and the role of HAIC in Western populations must be evaluated. The combined roles of HAIC with immunotherapy and delivery of chemotherapeutic drug nanoparticles to HCC tumour cells represents an exciting research and therapeutic strategy for advanced HCC.
Publish Date	2025-01-18 08:12
Citation	<p>Fung AKY, Chok KSH. Hepatic artery infusion chemotherapy: A resurgence. <i>World J Gastrointest Oncol</i> 2025; 17(2): 99612</p>
URL	https://www.wjgnet.com/1948-5204/full/v17/i2/99612.htm
DOI	https://dx.doi.org/10.4251/wjgo.v17.i2.99612

Full Article (PDF)	WJGO-17-99612-with-cover.pdf
Manuscript File	99612_Auto_Edited_014730.docx
Answering Reviewers	99612-answering-reviewers.pdf
Audio Core Tip	99612-audio.mp3
Conflict-of-Interest Disclosure Form	99612-conflict-of-interest-statement.pdf
Copyright License Agreement	99612-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	99612-non-native-speakers.pdf
Peer-review Report	99612-peer-reviews.pdf
Scientific Misconduct Check	99612-scientific-misconduct-check.png
Scientific Editor Work List	99612-scientific-editor-work-list.pdf
CrossCheck Report	99612-crosscheck-report.pdf